2012
DOI: 10.1128/cvi.00140-12
|View full text |Cite
|
Sign up to set email alerts
|

In VivoEfficacy of a Chimeric Peptide Derived from the Conserved Region of the M Protein against Group C and G Streptococci

Abstract: bThe J8 peptide from the conserved region of the M protein protects against group A streptococcus infections. In this study, we demonstrate that vaccination with a J8-containing formulation induces IgG that recognizes and binds group C and G streptococci. Moreover, this formulation has the potential to provide protection against infections caused by these organisms.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 32 publications
(9 reference statements)
0
2
0
Order By: Relevance
“…Although published data on preclinical efficacy of vaccine candidates in SDSE is limited beyond preliminary data on the J8 peptide 47 , the prevalence of conserved antigens suggest there may be cross-species effects of vaccines intended to target S. pyogenes . However, the sequence-based approach used in this study does not consider potential conserved structural epitopes which may confer antibody cross-reactivity or cross-opsonisation to divergent alleles.…”
Section: Discussionmentioning
confidence: 99%
“…Although published data on preclinical efficacy of vaccine candidates in SDSE is limited beyond preliminary data on the J8 peptide 47 , the prevalence of conserved antigens suggest there may be cross-species effects of vaccines intended to target S. pyogenes . However, the sequence-based approach used in this study does not consider potential conserved structural epitopes which may confer antibody cross-reactivity or cross-opsonisation to divergent alleles.…”
Section: Discussionmentioning
confidence: 99%
“…Over 25% of MGE insertion regions and MGE clusters were found to be conserved across Although published data on preclinical efficacy of vaccine candidates in SDSE is limited beyond preliminary data on the J8 peptide 46 , the prevalence of conserved antigens suggest there may be cross-species effects of vaccines intended to target S. pyogenes. However, the sequence-based approach used in this study does not consider potential conserved structural epitopes which may confer antibody cross-reactivity or cross-opsonisation to divergent alleles.…”
Section: Discussionmentioning
confidence: 99%